180 related articles for article (PubMed ID: 11858100)
21. Serum cytokine profiles in patients with adult onset Still's disease.
Choi JH; Suh CH; Lee YM; Suh YJ; Lee SK; Kim SS; Nahm DH; Park HS
J Rheumatol; 2003 Nov; 30(11):2422-7. PubMed ID: 14677188
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-6, soluble interleukin-2-receptor and soluble interleukin-6-receptor in sera of patients with rheumatoid arthritis: influences of disease activity and drug therapy.
Franke S; Herrmann D; Hein G; Müller A; Stein G
Eur J Med Res; 1997 Sep; 2(9):401-6. PubMed ID: 9300938
[TBL] [Abstract][Full Text] [Related]
23. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.
Dejica D
Roum Arch Microbiol Immunol; 2001; 60(3):183-201. PubMed ID: 12165973
[TBL] [Abstract][Full Text] [Related]
24. Effect of immunosuppressive cladribine treatment on serum leucocytes system in two-year clinical trial in patients with chronic progressive multiple sclerosis.
Janiec K; Wajgt A; Kondera-Anasz Z
Med Sci Monit; 2001; 7(1):93-8. PubMed ID: 11208501
[TBL] [Abstract][Full Text] [Related]
25. The roles of serum IL-18, IL-10, TNF-alpha and sIL-2R in patients with chronic hepatitis C.
Jia HY; Du J; Zhu SH; Ma YJ; Chen HY; Yang BS; Cai HF
Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):378-82. PubMed ID: 14607710
[TBL] [Abstract][Full Text] [Related]
26. [Changes of interleukin-2 and soluble interleukin-2 receptor serum level and multiple organ dysfunction syndrome in severely traumatic patients].
He Z; Wang S; Su Z; Huang Y; Yang J
Zhonghua Wai Ke Za Zhi; 1999 Aug; 37(8):492-3. PubMed ID: 11829898
[TBL] [Abstract][Full Text] [Related]
27. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease.
Evereklioglu C; Er H; Türköz Y; Cekmen M
Mediators Inflamm; 2002 Apr; 11(2):87-93. PubMed ID: 12061429
[TBL] [Abstract][Full Text] [Related]
28. Soluble immunological parameters and early prognosis of renal cell cancer patients.
Kallio JP; Tammela TL; Marttinen AT; Kellokumpu-Lehtinen PL
J Exp Clin Cancer Res; 2001 Dec; 20(4):523-8. PubMed ID: 11876546
[TBL] [Abstract][Full Text] [Related]
29. Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma.
Boyano MD; Garcia-Vázquez MD; López-Michelena T; Gardeazabal J; Bilbao J; Cañavate ML; Galdeano AG; Izu R; Díaz-Ramón L; Raton JA; Díaz-Pérez JL
Br J Cancer; 2000 Oct; 83(7):847-52. PubMed ID: 10970683
[TBL] [Abstract][Full Text] [Related]
30. [Effects of Jinlong Capsule on expressions of interleukin-2 and soluble interleukin-2 receptor in patients with primary liver cancer after transarterial chemoembolization therapy].
Zhang HJ; Yang JJ; Wang WX; Jiang X; Mao YJ; Yang CA; Guo JX
Zhong Xi Yi Jie He Xue Bao; 2008 Sep; 6(9):907-10. PubMed ID: 18782532
[TBL] [Abstract][Full Text] [Related]
31. The level of interleukin-2 and of soluble interleukin-2 receptor in patients with Balkan nephropathy.
Vöö S; Drugărin D; Mărgineanu F; Koreck A; Negru S; Biriescu A
Roum Arch Microbiol Immunol; 2002; 61(3):207-16. PubMed ID: 14752984
[TBL] [Abstract][Full Text] [Related]
32. Soluble interleukin-2 receptor and interleukin-4 in sera of asthmatic children before and after a prednisolone course.
Tang RB; Chen SJ
Ann Allergy Asthma Immunol; 2001 Mar; 86(3):314-7. PubMed ID: 11289331
[TBL] [Abstract][Full Text] [Related]
33. Gamma-interferon and soluble interleukin 2 receptor in tuberculous pleural effusion.
Kim YK; Lee SY; Kwon SS; Kim KH; Moon HS; Song JS; Park SH
Lung; 2001; 179(3):175-84. PubMed ID: 11891607
[TBL] [Abstract][Full Text] [Related]
34. Soluble interleukin-2 receptor in stage I-III melanoma.
Ottaiano A; Leonardi E; Simeone E; Ascierto PA; Scala S; Calemma R; Bryce J; Caracò C; Satriano RA; Gianfranco N; Franco R; Botti G; Castello G
Cytokine; 2006 Feb; 33(3):150-5. PubMed ID: 16517174
[TBL] [Abstract][Full Text] [Related]
35. The pro- and anti-inflammatory markers in patients with acute myocardial infarction and chronic stable angina.
Wojakowski W; Maslankiewicz K; Ochala A; Wyderka R; Zuk-Popiolek I; Flak Z; Mroz I; Tendera M
Int J Mol Med; 2004 Aug; 14(2):317-22. PubMed ID: 15254785
[TBL] [Abstract][Full Text] [Related]
36. Serum interleukin-2 (IL-2), soluble IL-2 receptors and tumor necrosis factor-alfa levels are significantly increased in acute myeloid leukemia patients.
Cimino G; Amadori S; Cava MC; De Sanctis V; Petti MC; Di Gregorio AO; Sgadari C; Vegna L; Cimino G; Mandelli F
Leukemia; 1991 Jan; 5(1):32-5. PubMed ID: 1999955
[TBL] [Abstract][Full Text] [Related]
37. Effect of neuroleptic administration on serum levels of soluble IL-2 receptor-alpha and IL-1 receptor antagonist in schizophrenic patients.
Sirota P; Meiman M; Herschko R; Bessler H
Psychiatry Res; 2005 Apr; 134(2):151-9. PubMed ID: 15840416
[TBL] [Abstract][Full Text] [Related]
38. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
[TBL] [Abstract][Full Text] [Related]
39. The effect of tramadol on serum cytokine response in patients undergoing pulmonary lobectomy.
Wang G; Weng Y; Ishiguro Y; Sakamoto H; Morita S
J Clin Anesth; 2005 Sep; 17(6):444-50. PubMed ID: 16171665
[TBL] [Abstract][Full Text] [Related]
40. [Serum IL-2 and sIL-2R concentration in children with chronic hepatitis B].
Pawłowska M; Halota W; Smukalska E; Grabczewska E
Pol Merkur Lekarski; 2005 Jan; 18(103):33-5. PubMed ID: 15859543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
